Skip to main content
. 2021 Apr 15;38(6):481–491. doi: 10.1007/s40266-021-00852-8

Table 4.

Adverse reactions and events

Expected Serious Total sample Arm 1 Arm 2
Study completed Drop-out Study completed Drop-out
Adverse reactions
 Allergic reaction, rash Yes No 3 0 1 1 1
 Headache Yes No 3 1 1 0 1
 Tachycardia, bradycardia Yes No 2 1 0 1 0
 Hypotension, vasodilation, syncope, edema Yes No 2 0 0 0 2
 Nausea, constipation, diarrhea, flatulence Yes No 3 0 0 1 2
 Hypertension, agitation No No 1 0 1 0 0
 Total adverse reactions 14 2 3 3 6
 Trial drug decreased due to adverse reaction 1 0 0 1 0
 Withdrawn due to adverse reaction 4 0 1 0 3
Adverse events
 Cerebral hemorrhage No Yes 1 0 1 0 0
 Incidental carcinoma diagnosis No Yes 3 0 0 3 0
 Varicella zoster virus infection relapse No No 1 1 0 0 0
 Total adverse events 5 1 1 3 0
 Trial drug decreased due to adverse event 0 0 0 0 0
 Withdrawn due to adverse event 1 0 1 0 0